These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7763010

  • 1. In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background.
    Nielsen LL, Gurnani M, Catino JJ, Tyler RD.
    Anticancer Res; 1995; 15(2):385-92. PubMed ID: 7763010
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs.
    Nielsen LL, Gurnani M, Tyler RD.
    Cancer Res; 1992 Jul 01; 52(13):3733-8. PubMed ID: 1617645
    [Abstract] [Full Text] [Related]

  • 3. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
    Nielsen LL, Discafani CM, Gurnani M, Tyler RD.
    Cancer Res; 1991 Jul 15; 51(14):3762-7. PubMed ID: 2065330
    [Abstract] [Full Text] [Related]

  • 4. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.
    Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493
    [Abstract] [Full Text] [Related]

  • 5. Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumor.
    Nielsen LL, Gurnani M, Porter G, Trexler S, Emerson D, Tyler RD.
    In Vivo; 1994 Apr 15; 8(3):295-302. PubMed ID: 7803707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A transgenic mouse model for mammary carcinogenesis.
    Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM.
    Oncogene; 1998 Feb 26; 16(8):997-1007. PubMed ID: 9519874
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.
    Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM.
    Oncogene; 2000 Feb 17; 19(7):889-98. PubMed ID: 10702797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
    Witty JP, Lempka T, Coffey RJ, Matrisian LM.
    Cancer Res; 1995 Apr 01; 55(7):1401-6. PubMed ID: 7882342
    [Abstract] [Full Text] [Related]

  • 15. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
    Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM.
    Cancer Res; 2000 Jul 01; 60(13):3569-76. PubMed ID: 10910070
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.